Home
Nona Biosciences

Nona Biosciences Market Share Analysis for March 2026

Discover Nona Biosciences' pioneering fully human heavy chain only antibodies (HCAb/VHH) Harbour Mice® platform, driving innovation in next-gen therapeutic modalities. Explore how our advanced single-domain antibody technology accelerates the development of bispecifics, ADCs, CAR-T therapies, and more.

Industry: N/A

Domainnonabio.com

Year Founded2022

Employees51 - 200

Annual Revenue--

Nona Biosciences

Nona Biosciences (including company regionals)

nonabio.com

See more website traffic and engagement information

Total visits to Nona Biosciences's top domains

Understand Nona Biosciences market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

nonabio.com10K

See more with Sales Intelligence

Avg. visit duration in Nona Biosciences's top domains

Analyze Nona Biosciences engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

nonabio.com00:00:02

See more with Sales Intelligence

Avg. pageviews on Nona Biosciences's top domains

See how Nona Biosciences keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

nonabio.com1.34

See more with Sales Intelligence

Nona Biosciences top competitors by domain

Top similar sites in March 2026, ranked by their affinity

harbourbiomed.comCompany NameHarbour BioMedEmployees51 - 200HQUnited States, Massachusetts, CambridgeAnnual revenue$25M - $50MTotal visits6.3KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Nona Biosciences

These are the website technologies, by industry, used by Nona Biosciences top domains

Advertising (5)

DoubleClick

Widget (5)

Twemoji

Mobile (3)

Meta Viewport

Conversion & Analytics (2)

Google Analytics

More Technologies

9

See all

News & Signals from Nona Biosciences

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsNonabio partnered with Link Cell Therapies, Inc on Jan 9th '26.Nona Biosciences ("Nona"), a global biotechnology company advancing biologics discovery through innovative technology platforms, today announced that it has entered into a multi-target antibody discovery collaboration with Link Cell Therapies.

NewsValinktx partnered with Nonabio on Dec 17th '25.December 17, 2025 - Cambridge, USA and London, UK - Valink Therapeutics ("Valink"), a private biotechnology company developing next-generation therapeutics with a focus on bispecific antibody-drug conjugates (bsADCs) and complementary modalities, and Nona Biosciences ("Nona"), a global biotechnology company providing integrated solutions for biological drug discovery and development from "Idea to IND" (I to I(R), today announced the formation of a strategic biologics discovery alliance.

NewsNonabio hired Hongjiang Miao as Chief AI Officer on Dec 4th '25.CAMBRIDGE, Mass., Dec. 3, 2025 /PRNewswire/ - Nona Biosciences ("Nona" or the "Company"), a global biotechnology company providing integrated solutions for biological drug discovery and development from I to I(R)(Idea to IND), today announced the appointment of Dr. Hongjiang Miao as Chief AI Officer.